Studies of Immunologically-Mediated Kidney Diseases

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Kidney diseases related to the immune system include, nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with connective tissue disorders. This study will allow researchers to admit and follow patients suffering from autoimmune diseases of the kidney. It will attempt to provide information about the causes and specific abnormalities associated with autoimmune kidney disease. Patients with kidney disease as a result of their immune system, and patients with diseases of the immune system who may later develop kidney disease, will be potential subjects for this study. Patients will undergo a history and physical examination, and standard laboratory test to more closely understand the causes, signs, symptoms, and responses to medication of these diseases. Based on these evaluations the patients may qualify as candidates for other experimental studies. At any time these patients may be asked to submit blood or urine samples for further research....

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Healthy Volunteers: f
View:

∙ In order to be eligible to participate in this study, a participant must meet all of the following criteria:

• Adults \>= 18 years of age and children 10-17 years of age

• Participants with

‣ known, proven, or suspected immunologically-mediated kidney diseases, including but not limited to nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with other systemic or connective tissue disorders, OR

⁃ immunologically-mediated diseases with the potential for kidney disease.

• Ability of the participant or guardian to understand and the willingness of the participant or guardian to provide written informed consent.

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Meryl A Waldman, M.D.
waldmanm@mail.nih.gov
(301) 451-6990
Time Frame
Start Date: 1992-06-25
Participants
Target number of participants: 2000
Treatments
Patients
Patients with known or suspected immunologically-mediated kidney diseases or immunologically-mediated diseases with potential for kidney disease.
Authors
Howard A Austin
Sponsors
Leads: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

This content was sourced from clinicaltrials.gov